AAPL276.87-16.30 (-5.56%) ▼|ABBV243.40+8.51 (+3.62%) ▲|ABT93.41+2.92 (+3.23%) ▲|ACN126.06-3.09 (-2.39%) ▼|ADBE194.83-1.72 (-0.88%) ▼|AMAT649.59+60.63 (+10.29%) ▲|AMD522.26+3.21 (+0.62%) ▲|AMGN355.43+4.04 (+1.15%) ▲|AMT169.17-5.29 (-3.03%) ▼|AMZN228.48-5.90 (-2.52%) ▼|AVGO377.83-4.25 (-1.11%) ▼|AXP341.70-0.87 (-0.25%) ▼|BA218.27-1.98 (-0.90%) ▼|BAC58.13+0.40 (+0.69%) ▲|BKNG179.87-1.41 (-0.78%) ▼|BLK969.50-13.10 (-1.33%) ▼|BMY55.52+0.52 (+0.94%) ▲|BNY145.20+1.64 (+1.14%) ▲|BRK-B489.00-5.81 (-1.17%) ▼|C145.18+1.59 (+1.10%) ▲|CAT1,048.63+54.18 (+5.45%) ▲|CL91.37-0.51 (-0.56%) ▼|CMCSA22.90+0.26 (+1.13%) ▲|COF203.80+3.32 (+1.66%) ▲|COP106.64-0.28 (-0.26%) ▼|COST948.77-12.20 (-1.27%) ▼|CRM150.63-2.13 (-1.40%) ▼|CSCO118.61-1.13 (-0.94%) ▼|CVS104.29+2.42 (+2.38%) ▲|CVX172.36+0.91 (+0.53%) ▲|DE624.00+23.25 (+3.87%) ▲|DHR194.53+5.66 (+2.99%) ▲|DIS98.54-2.58 (-2.55%) ▼|DUK127.56+1.03 (+0.81%) ▲|EMR143.49+2.05 (+1.45%) ▲|FDX325.49+8.66 (+2.73%) ▲|GD344.69+0.37 (+0.11%) ▲|GE370.44+4.56 (+1.25%) ▲|GEV1,083.29+25.64 (+2.42%) ▲|GILD124.31-0.84 (-0.67%) ▼|GM78.56-0.39 (-0.49%) ▼|GOOG340.73-4.30 (-1.24%) ▼|GOOGL343.06-2.22 (-0.64%) ▼|GS1,068.10-8.82 (-0.82%) ▼|HD343.40+0.54 (+0.16%) ▲|HON231.19+3.77 (+1.66%) ▲|IBM257.99-4.97 (-1.89%) ▼|INTC129.52-2.39 (-1.81%) ▼|INTU255.71-6.63 (-2.53%) ▼|ISRG400.66-1.17 (-0.29%) ▼|JNJ245.43+4.43 (+1.84%) ▲|JPM335.61+2.16 (+0.65%) ▲|KO80.50-0.11 (-0.13%) ▼|LIN524.35+8.62 (+1.67%) ▲|LLY1,131.92+14.66 (+1.31%) ▲|LMT505.65+14.01 (+2.85%) ▲|LOW221.09-0.36 (-0.16%) ▼|LRCX392.12+17.30 (+4.61%) ▲|MA494.35-0.06 (-0.01%) ▼|MCD267.09-6.79 (-2.48%) ▼|MDLZ61.73-0.01 (-0.02%) ▼|MDT80.84+0.71 (+0.89%) ▲|META546.17-11.64 (-2.09%) ▼|MMM167.19+1.28 (+0.77%) ▲|MO73.39+1.32 (+1.82%) ▲|MRK125.75+5.15 (+4.27%) ▲|MS221.07+1.21 (+0.55%) ▲|MSFT353.83-11.62 (-3.18%) ▼|MU1,200.00+152.08 (+14.51%) ▲|NEE87.93+0.31 (+0.35%) ▲|NFLX72.26+0.42 (+0.58%) ▲|NKE40.64-1.18 (-2.82%) ▼|NOW90.19-3.62 (-3.85%) ▼|NVDA193.88-5.04 (-2.53%) ▼|ORCL152.00-5.53 (-3.51%) ▼|PEP140.19-2.08 (-1.46%) ▼|PFE23.75-0.29 (-1.21%) ▼|PG148.67-3.37 (-2.22%) ▼|PLTR107.18-6.33 (-5.58%) ▼|PM179.18+1.87 (+1.05%) ▲|QCOM205.93+8.61 (+4.36%) ▲|RTX186.02+0.96 (+0.52%) ▲|SBUX103.23-0.30 (-0.29%) ▼|SCHW89.48-1.91 (-2.09%) ▼|SO95.92+0.14 (+0.15%) ▲|SPG225.83+3.68 (+1.65%) ▲|T22.54+0.17 (+0.74%) ▲|TMO506.28+14.08 (+2.86%) ▲|TMUS182.61+1.82 (+1.01%) ▲|TSLA373.52-1.95 (-0.52%) ▼|TXN310.29+7.18 (+2.37%) ▲|UBER72.77-1.09 (-1.47%) ▼|UNH414.94+9.14 (+2.25%) ▲|UNP266.60+6.64 (+2.55%) ▲|UPS108.46+2.32 (+2.18%) ▲|USB60.97+0.86 (+1.42%) ▲|V334.17+1.94 (+0.58%) ▲|VZ46.21+0.53 (+1.15%) ▲|WFC84.90+0.60 (+0.71%) ▲|WMT116.42-2.60 (-2.18%) ▼|XOM137.46+0.56 (+0.41%) ▲|AAPL276.87-16.30 (-5.56%) ▼|ABBV243.40+8.51 (+3.62%) ▲|ABT93.41+2.92 (+3.23%) ▲|ACN126.06-3.09 (-2.39%) ▼|ADBE194.83-1.72 (-0.88%) ▼|AMAT649.59+60.63 (+10.29%) ▲|AMD522.26+3.21 (+0.62%) ▲|AMGN355.43+4.04 (+1.15%) ▲|AMT169.17-5.29 (-3.03%) ▼|AMZN228.48-5.90 (-2.52%) ▼|AVGO377.83-4.25 (-1.11%) ▼|AXP341.70-0.87 (-0.25%) ▼|BA218.27-1.98 (-0.90%) ▼|BAC58.13+0.40 (+0.69%) ▲|BKNG179.87-1.41 (-0.78%) ▼|BLK969.50-13.10 (-1.33%) ▼|BMY55.52+0.52 (+0.94%) ▲|BNY145.20+1.64 (+1.14%) ▲|BRK-B489.00-5.81 (-1.17%) ▼|C145.18+1.59 (+1.10%) ▲|CAT1,048.63+54.18 (+5.45%) ▲|CL91.37-0.51 (-0.56%) ▼|CMCSA22.90+0.26 (+1.13%) ▲|COF203.80+3.32 (+1.66%) ▲|COP106.64-0.28 (-0.26%) ▼|COST948.77-12.20 (-1.27%) ▼|CRM150.63-2.13 (-1.40%) ▼|CSCO118.61-1.13 (-0.94%) ▼|CVS104.29+2.42 (+2.38%) ▲|CVX172.36+0.91 (+0.53%) ▲|DE624.00+23.25 (+3.87%) ▲|DHR194.53+5.66 (+2.99%) ▲|DIS98.54-2.58 (-2.55%) ▼|DUK127.56+1.03 (+0.81%) ▲|EMR143.49+2.05 (+1.45%) ▲|FDX325.49+8.66 (+2.73%) ▲|GD344.69+0.37 (+0.11%) ▲|GE370.44+4.56 (+1.25%) ▲|GEV1,083.29+25.64 (+2.42%) ▲|GILD124.31-0.84 (-0.67%) ▼|GM78.56-0.39 (-0.49%) ▼|GOOG340.73-4.30 (-1.24%) ▼|GOOGL343.06-2.22 (-0.64%) ▼|GS1,068.10-8.82 (-0.82%) ▼|HD343.40+0.54 (+0.16%) ▲|HON231.19+3.77 (+1.66%) ▲|IBM257.99-4.97 (-1.89%) ▼|INTC129.52-2.39 (-1.81%) ▼|INTU255.71-6.63 (-2.53%) ▼|ISRG400.66-1.17 (-0.29%) ▼|JNJ245.43+4.43 (+1.84%) ▲|JPM335.61+2.16 (+0.65%) ▲|KO80.50-0.11 (-0.13%) ▼|LIN524.35+8.62 (+1.67%) ▲|LLY1,131.92+14.66 (+1.31%) ▲|LMT505.65+14.01 (+2.85%) ▲|LOW221.09-0.36 (-0.16%) ▼|LRCX392.12+17.30 (+4.61%) ▲|MA494.35-0.06 (-0.01%) ▼|MCD267.09-6.79 (-2.48%) ▼|MDLZ61.73-0.01 (-0.02%) ▼|MDT80.84+0.71 (+0.89%) ▲|META546.17-11.64 (-2.09%) ▼|MMM167.19+1.28 (+0.77%) ▲|MO73.39+1.32 (+1.82%) ▲|MRK125.75+5.15 (+4.27%) ▲|MS221.07+1.21 (+0.55%) ▲|MSFT353.83-11.62 (-3.18%) ▼|MU1,200.00+152.08 (+14.51%) ▲|NEE87.93+0.31 (+0.35%) ▲|NFLX72.26+0.42 (+0.58%) ▲|NKE40.64-1.18 (-2.82%) ▼|NOW90.19-3.62 (-3.85%) ▼|NVDA193.88-5.04 (-2.53%) ▼|ORCL152.00-5.53 (-3.51%) ▼|PEP140.19-2.08 (-1.46%) ▼|PFE23.75-0.29 (-1.21%) ▼|PG148.67-3.37 (-2.22%) ▼|PLTR107.18-6.33 (-5.58%) ▼|PM179.18+1.87 (+1.05%) ▲|QCOM205.93+8.61 (+4.36%) ▲|RTX186.02+0.96 (+0.52%) ▲|SBUX103.23-0.30 (-0.29%) ▼|SCHW89.48-1.91 (-2.09%) ▼|SO95.92+0.14 (+0.15%) ▲|SPG225.83+3.68 (+1.65%) ▲|T22.54+0.17 (+0.74%) ▲|TMO506.28+14.08 (+2.86%) ▲|TMUS182.61+1.82 (+1.01%) ▲|TSLA373.52-1.95 (-0.52%) ▼|TXN310.29+7.18 (+2.37%) ▲|UBER72.77-1.09 (-1.47%) ▼|UNH414.94+9.14 (+2.25%) ▲|UNP266.60+6.64 (+2.55%) ▲|UPS108.46+2.32 (+2.18%) ▲|USB60.97+0.86 (+1.42%) ▲|V334.17+1.94 (+0.58%) ▲|VZ46.21+0.53 (+1.15%) ▲|WFC84.90+0.60 (+0.71%) ▲|WMT116.42-2.60 (-2.18%) ▼|XOM137.46+0.56 (+0.41%) ▲|
28.3 C
New York
Thursday, June 25, 2026

Tag: biotechnology

newssourceFORcompanyinformationcontent1marketreleases

Persica strengthens global IP portfolio with EU patent granted for PP353

London, UK, 11 June 2025 - Persica Pharmaceuticals Limited (Persica), a clinical stage biotechnology company developing a transformative treatment for chronic Low Back Pain (cLBP), today announces that it has been granted a patent by the European Patent Office for PP353, its clinical stage asset.

NX Belgium Opens New Logistics Base at Brussels Airport’s Brucargo Central

- Expands Services as Logistics Hub for Healthcare Industry in Europe - TOKYO, June 11, 2025 /PRNewswire/ -- Nippon Express (Belgium) NV/SA (hereinafter "NX Belgium"),...

Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU

US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in Europe 
US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in Europe

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers...

Philochem Licensing of OncoACP3 to RayzeBio for potential value of up to $1.35bn plus royalties

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced it will release topline data from the norovirus Phase I trial before the market open on Wednesday, June 11, 2025. The Vaxart senior management team will host a live conference call on the same date beginning at 8:30 a.m. Eastern Time to review the data and provide a trial update.

IV Therapy & Vein Access: Innovations Driving the Global Healthcare Market

"Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly into the bloodstream. The global market for...

Wireline Services Market Size Poised to Reach USD 28.30 Billion by 2031, Experiences Growth Due to Increasing Demand | The Insight Partners

NEW YORK, June 10, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global wireline services market is observing...

Exosome Research Market worth US$480.6 million by 2030 with 17.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., June 10, 2025 /PRNewswire/ -- The global Exosome Research Market, valued at US$189.4 million in 2024 stood at US$214.4 million in 2025...

The Chicago School Launches Online Master of Science Program in Biomedical Sciences

CHICAGO, June 10, 2025 /PRNewswire/ -- The Chicago School today announced a new Master of Science (MS) Biomedical Sciences program in the College of Graduate and...

Phenomix and Mayo Clinic Publish Research Demonstrating Utility of MyPhenome Test for Personalized GLP-1 and Phen-Top Treatment

Published in Cell Metabolism, the Phenomix and Mayo Clinic research shows the MyPhenome™ test can help providers guide obesity treatment by matching patients to GLP-1s...

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One

ZINZINO AB (PUBL.): Zinzino acquires assets from Ecosystem for increased distribution power in France and DOM-TOM

GOTHENBURG, Sweden, June 10, 2025 /PRNewswire/ -- Zinzino, the global health and wellness brand from Scandinavia, has acquired the rights to French direct selling...

Sanyou Biopharmaceuticals and Medicovestor, Inc. Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates

SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the...

Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy

LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United States and Europe,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBiotechnology

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers